(4S,8AR)-4-PHENYL-8A-METHYLPERHYDROPYRROLO-[1,2-A]-PYRAZINE-1,3,6-TRIONE
Compound with spectra: 1 NMR
![(4S,8AR)-4-PHENYL-8A-METHYLPERHYDROPYRROLO-[1,2-A]-PYRAZINE-1,3,6-TRIONE](/api/compound/4HfqF75Wbz3.png?ph=true&h=300&w=458 "(4S,8AR)-4-PHENYL-8A-METHYLPERHYDROPYRROLO-[1,2-A]-PYRAZINE-1,3,6-TRIONE")
| SpectraBase Compound ID | 4HfqF75Wbz3 |
|---|---|
| InChI | InChI=1S/C14H14N2O3/c1-14-8-7-10(17)16(14)11(12(18)15-13(14)19)9-5-3-2-4-6-9/h2-6,11H,7-8H2,1H3,(H,15,18,19)/t11-,14+/m0/s1 |
| InChIKey | AUGCSVDMFQZGDI-SMDDNHRTSA-N |
| Mol Weight | 258.28 g/mol |
| Molecular Formula | C14H14N2O3 |
| Exact Mass | 258.100442 g/mol |
| Enantiomer InChIKey | AUGCSVDMFQZGDI-RISCZKNCSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
METHYL-(2S,ALPHA-S)-ALPHA-[2-(TERT.-BUTYLCARBAMOYL)-2-METHYL-5-OXO-PYRROLIDIN-1-YL]-ALPHA-PHENYLACETATE
METHYL-(2R,ALPHA-S)-ALPHA-[2-(TERT.-BUTYLCARBAMOYL)-2-METHYL-5-OXO-PYRROLIDIN-1-YL]-ALPHA-PHENYLACETATE
2-pyrrolidinone, 5-phenyl-1-(phenylmethyl)-5-(1-piperidinylcarbonyl)-
1-Benzyl-5-(morpholine-4-carbonyl)-5-phenyl-pyrrolidin-2-one
2-benzyl-1,4-dioxo-3-ethyloctahydropyrrolo[1,2-a]pyrazin-6-carboxy-p-toluidide
benzamide, 4-(acetylamino)-N-[1-[[(2,6-dimethylphenyl)amino]carbonyl]cyclohexyl]-N-[2-(1H-indol-3-yl)ethyl]-
N-[(2-Azidophenyl)(butylcarbamoyl)methyl]-N,3-diphenylpropanamide
5-Phenyl-5-(1-piperidinyl)-1,3-bis[2-(1-piperidinyl)ethyl]-1,3-diazinane-2,4,6-trione
(+)-(3S,4R,1'R)-3-(4-Methoxyphenyl)-1-(1-phenylethyl)-4-pyridin-2-ylazetidin-2-one
4-Cyclohexyl-1-(4-methylbenzoyl)-1,4-diazaspiro[5.5]undecane-3,5-dione
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of New Perhydropyrrolo[1,2-a]pyrazine Derivatives and Their Evaluation in Animal Models of Epilepsy | Molecules | 2014 |